24 April 2012 15:34 [Source: ICIS news]
LONDON (ICIS)--Merck plans to close its Serono pharmaceuticals headquarters in ?xml:namespace>
As a consequence, Merck said that out of the 1,250 positions in
Despite these planned measures, the group said Merck Serono will maintain a manufacturing presence in Switzerland, continuing to manufacture biotech products in its biotech production sites in Aubonne and Corsier-sur-Vevey, Canton of Vaud.
Merck expects to implement the closure and job cuts in the first half of 2013.
“The planned measures for Merck Serono’s operations in
“We are committed to working closely with key stakeholders, especially affected employees, to find socially responsible solutions, including exploring potential entrepreneur partnership programmes and redeployment proposals,” Oschmann added.
In February, the company announced plans to job cuts but at the time did disclose details.
Merck acquired Serono in 2006.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|